The Alliance

Innovation Corner

The Alliance Innovation Corner is a regular publication of The Alliance National Innovation Council that champions novel approaches, groundbreaking strategies and transformative initiatives to advance the field of donation and transplantation. Through real-world accounts and insightful narratives, this series explores the shared experiences of community leaders, spotlighting lessons learned along the way.

Innovation Corner Past Issues

The Alliance Insight Series

Feedback & Suggestions Welcome

Your input is valuable to us as it helps improve our programs and offerings in order to provide you with vital updates and essential information. Please feel free to share your thoughts and ideas with us.

A Note About Content

Some legacy resources on this website may refer to UNOS in place of the OPTN, reflecting common usage at the time of publication when the two were often used interchangeably. In recent years, significant work has gone into distinguishing these as separate entities: the OPTN is the nationwide organ transplant network established by federal law, while UNOS is one of several organizations currently under contract to support OPTN operations. We’ve preserved these resources as originally published, but recommend referring to current terminology for the most accurate understanding of each organization’s role.

Molecular Structure
Dr. Bonnie E. Lonze, Director of Research at NYU Langone Transplant Institute, highlights the limitations of current antigen matching techniques and introduces eplet mismatching analysis as a more precise method to assess immunologic compatibility between donors and recipients. Lonze recently presentated this information at The Alliance 2024 National Innovation Forum: The Future of Organs for Transplant.

Optimizing Transplant Outcomes Through Molecular Matching

Challenge:

The suboptimal long-term survival rates of transplanted organs despite improvements in short-term outcomes. This issue is primarily attributed to the toxicities of immunosuppressive therapies, which can lead to significant side effects, including infections, malignancies, new-onset diabetes, cardiovascular disease, and nephrotoxicity. Tacrolimus, a key immunosuppressant, is particularly noted for its nephrotoxic effects.

Objectives of the Clinical Intervention:

To improve long-term transplant outcomes by optimizing immunologic matching between donors and recipients at a molecular level. The goal is to reduce the reliance on high-dose immunosuppression, mitigating its associated toxicities and enhancing graft survival, patient survival, and overall quality of life for transplant recipients.

Key Insights:

  1. Introduction of Eplet Mismatching Analysis: This method uses high-resolution genotyping to identify specific molecular differences between donor and recipient HLA molecules. Eplets are defined as short stretches of polymorphic residues within HLA molecules accessible to antibodies.
  2. Comparison with Traditional Antigen Matching: Traditional antigen matching, used since the 1960s,is based on serologic typing and is limited in its ability to differentiate between different alleles within an antigen group. Eplet mismatching provides a more granular analysis, identifying specific mismatches that can influence immunologic responses.
  3. Implementation of Pilot Studies: Dr. Lonze’s team conducted a pilot study with deceased donor kidney transplant recipients who were identified as having low eplet mismatches. These patients were placed on a protocol with reduced immunosuppression, including discontinuing steroids and lowered tacrolimus dosing. Preliminary results from four patients followed for over a year showed excellent renal function and no episodes of rejection or formation of donor-specific antibodies.
  4. Validation and Future Research: Research by Peter Nickerson’s (MD) group demonstrated that lower eplet mismatches correlate with reduced risk of T cell-mediated rejection, antibody-mediated rejection, and the formation of de novo donor-specific antibodies. Dr. Lonze called for further studies, including randomized controlled trials, to validate these findings and refine risk stratification systems.

Findings:

  • Preliminary Pilot Study Results: The four patients in the pilot study had a median estimated glomerular filtration rate (eGFR) of 89 and a median creatinine level of 0.87, indicating excellent renal function.
  • Research Findings from Winnipeg Group: Data showed a stepwise decrease in T cell-mediated rejection risk as eplet mismatches decreased. Low-risk patients had significantly better outcomes regarding rejection-free survival and reduced formation of de novo donor-specific antibodies over a ten-year follow-up period.

Conclusion:

Dr. Lonze concluded that eplet mismatching represents a significant advancement over traditional antigen matching, offering a more detailed assessment of immunologic risk. This approach can reduce immunosuppression in low-risk patients, improving long-term graft survival and patient outcomes. She emphasized the importance of ongoing research to refine this technology and explore its application across different types of organ transplants. The presentation highlighted the need for improved typing technologies and suggested that, in the future, eplet mismatching could be integrated into donor-recipient matching processes, potentially transforming transplant medicine.

Helpful Resources

Check out our Alliance On-Demand Learning Pathways, featuring “The Future of Organs for Transplant.”

Questions & Comments

Please send all questions and/or feedback to info@organdonationalliance.org.

Worth Sharing
Dr. Bonnie E. Lonze Infographic 7.17.24 (1)

A Special Thanks to This Series’ Contributors

Bonnie E Lonze Square
Speaker
Bonnie Lonze
MD, PhD
NYU Langone Transplant Institute
Reef Pref 1
About the Editor |
Michelle Reef

Michelle Reef joined Mississippi Organ Recovery Agency (MORA) in November 2022 as the Vice President, Family, Partner & Tissue Services. In this role, Michelle provides strategic direction and leadership for the Communications Center, Family Care, Hospital Development, Referral Management, and Tissue Recovery Services. Prior to becoming part of the MORA team, Michelle spent almost eleven years at Gift of Hope Organ & Tissue Donor Network in Illinois where she was the Director of Hospital & Partner Relations. Michelle is proud to serve the mission of MORA and draws upon over twenty years of healthcare knowledge and experience to assist in reaching the organizational goals and objectives. In 2022, Michelle graduated with high distinction from Liberty University with her Master of Arts in Executive Leadership and became part of the Sigma Beta Delta International Honor Society in Business, Management, and Administration. Additionally, she earned coaching and leadership certifications from GiANT Worldwide and is enthusiastic about mentoring and growing new leaders. She serves on multiple committees with industry partners, including AOPO, DLA, NATCO and The Alliance and enjoys networking in the donation and transplantation community as well as with several Women in Leadership organizations. In October 2022, Michelle was presented the Rising Leader award from The Alliance for her commitment and work in the industry, which was a true honor and humbling experience. Lastly, Michelle is a former graduate of the Art and Science of Leadership program through the Gift of Life Institute and is certified in Healthcare Simulation Debriefing & Facilitating from Jump Trading, Simulation & Education Center in Peoria, IL. Michelle is committed to advancing the mission of saving and improving lives through the gift of donation and transplantation.

AA6026DE 8812 48C8 B959 6C8ED04900A8 1 201 A
About the Editor |
Anya Shah

Anya Shah is a third-year student at the University of Alabama at Birmingham. She is pursuing her Bachelors degree in Public Health at the Ryals School of Public Health and minoring in Forensic Science. She is interested in pursuing a career in Health Science.

During her time at UAB, Anya has taken on several leadership roles. She is currently the Logistics Manager of UAB’s Blazaraas Dance Team. She is also involved in the UAB Student Housing Advisory Group and the UAB Student of Health Professions Emerging Leaders Program.

Additionally, Anya actively pursues her interests cooking and baking. She enjoys traveling internationally and immersing in new cultures. Anya is originally from Atlanta, Georgia where she graduated from Johns Creek High School with honors.

Advancing All.

The Alliance is not a membership organization and therefore relies on annual voluntary financial support from OPOs and transplant programs who find value in our programs and initiatives.

We invite you to join us as a professional partner